Rajash K Handa1, Ziyue Liu2, Bret A Connors3, Mouhamad Alloosh4, David P Basile4, Johnathan D Tune4, Michael Sturek4, Andrew P Evan3, James E Lingeman5. 1. Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, Indiana. Electronic address: rajash_handa@hotmail.com. 2. Department of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana. 3. Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, Indiana. 4. Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, Indiana. 5. Kidney Stone Institute of Indiana University Health Methodist Hospital, Indianapolis, Indiana.
Abstract
PURPOSE: We performed a pilot study to assess whether renal shock wave lithotripsy influences metabolic syndrome onset and severity. MATERIALS AND METHODS: Three-month-old juvenile female Ossabaw miniature pigs were treated with shock wave lithotripsy (2,000 shock waves at 24 kV with 120 shock waves per minute in 2) or sham shock wave lithotripsy (no shock waves in 2). Shock waves were targeted to the upper pole of the left kidney to model treatment that would also expose the pancreatic tail to shock waves. Pigs were then instrumented to directly measure arterial blood pressure via an implanted radiotelemetry device. They later received a hypercaloric atherogenic diet for about 7 months. Metabolic syndrome development was assessed by the intravenous glucose tolerance test. RESULTS: Metabolic syndrome progression and severity were similar in the sham treated and lithotripsy groups. The only exception arterial blood pressure, which remained relatively constant in sham treated pigs but began to increase at about 2 months towards hypertensive levels in lithotripsy treated pigs. Metabolic data on the 2 groups were pooled to provide a more complete assessment of metabolic syndrome development and progression in this juvenile pig model. The intravenous glucose tolerance test revealed substantial insulin resistance with impaired glucose tolerance within 2 months on the hypercaloric atherogenic diet with signs of further metabolic impairment at 7 months. CONCLUSIONS: These preliminary results suggest that renal shock wave lithotripsy is not a risk factor for worsening glucose tolerance or diabetes mellitus onset. However, it appears to be a risk factor for early onset hypertension in metabolic syndrome.
PURPOSE: We performed a pilot study to assess whether renal shock wave lithotripsy influences metabolic syndrome onset and severity. MATERIALS AND METHODS: Three-month-old juvenile female Ossabaw miniature pigs were treated with shock wave lithotripsy (2,000 shock waves at 24 kV with 120 shock waves per minute in 2) or sham shock wave lithotripsy (no shock waves in 2). Shock waves were targeted to the upper pole of the left kidney to model treatment that would also expose the pancreatic tail to shock waves. Pigs were then instrumented to directly measure arterial blood pressure via an implanted radiotelemetry device. They later received a hypercaloric atherogenic diet for about 7 months. Metabolic syndrome development was assessed by the intravenous glucose tolerance test. RESULTS:Metabolic syndrome progression and severity were similar in the sham treated and lithotripsy groups. The only exception arterial blood pressure, which remained relatively constant in sham treated pigs but began to increase at about 2 months towards hypertensive levels in lithotripsy treated pigs. Metabolic data on the 2 groups were pooled to provide a more complete assessment of metabolic syndrome development and progression in this juvenile pig model. The intravenous glucose tolerance test revealed substantial insulin resistance with impaired glucose tolerance within 2 months on the hypercaloric atherogenic diet with signs of further metabolic impairment at 7 months. CONCLUSIONS: These preliminary results suggest that renal shock wave lithotripsy is not a risk factor for worsening glucose tolerance or diabetes mellitus onset. However, it appears to be a risk factor for early onset hypertension in metabolic syndrome.
Authors: Rajash K Handa; Andrew P Evan; Bret A Connors; Cynthia D Johnson; Ziyue Liu; Mouhamad Alloosh; Michael Sturek; Carmella Evans-Molina; Jessica A Mandeville; Ehud Gnessin; James E Lingeman Journal: J Urol Date: 2014-03-18 Impact factor: 7.450
Authors: Mitra de Cógáin; Amy E Krambeck; Andrew D Rule; Xujian Li; Eric J Bergstralh; Matthew T Gettman; John C Lieske Journal: Urology Date: 2011-11-16 Impact factor: 2.649
Authors: Hassan Razvi; Andrew Fuller; Linda Nott; Carlos E Méndez-Probst; Rasmus Leistner; Kirsten Foell; Sumit Davé; John D Denstedt Journal: J Endourol Date: 2012-08-27 Impact factor: 2.942
Authors: Ahmed R El-Nahas; Bassam A Awad; Ahmed M El-Assmy; Mohamed E Abou El-Ghar; Ibrahim Eraky; Mahmoud R El-Kenawy; Khaled Z Sheir Journal: BJU Int Date: 2012-08-23 Impact factor: 5.588
Authors: Rajash K Handa; James E Lingeman; Sharon B Bledsoe; Andrew P Evan; Bret A Connors; Cynthia D Johnson Journal: Urolithiasis Date: 2015-11-02 Impact factor: 3.436